ClinicalTrials.gov
ClinicalTrials.gov Menu

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (BEACON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01351675
Recruitment Status : Terminated (IDMC recommendation for safety concerns)
First Posted : May 11, 2011
Last Update Posted : May 14, 2014
Sponsor:
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : December 2012
  Certification/Extension First Submitted : April 28, 2014